$TJX

Canestrari Kenneth sold $5.0M of TJX

Canestrari Kenneth (SEVP - Group President) sold 31,447 shares of TJX COMPANIES INC /DE/ (TJX) at $157.50 ($4.95M total) on 2026-06-03.

Original reporting
SEC EDGAR · Canestrari Kenneth
Published Jun 5, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 5, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TJX
Neutral
medium confidence
Mentioned
$TJX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TJXNeutralLow
01

Why it matters

This provides a datapoint on insider behavior but does not include earnings, guidance, or deal information that would typically reprice the stock materially.

02

Market read

Traders may monitor for follow-on insider activity, but the filing alone is unlikely to drive a durable repricing.

03

What to watch

Insider sales can be pre-scheduled for personal liquidity; one transaction does not establish a trend or new information about TJX fundamentals.

Relevance 6/10Novelty 6/10Timing: SEC Form 4 filed today; sale executed 2026-06-03

Background

The article is an SEC Form 4 insider transaction disclosure for TJX, showing an officer’s open-market sale.

Company-level read

Ticker impact

$TJXNeutralMedium confidence
Context

TJX officer Canestrari Kenneth sold ~$4.95M of TJX shares in an open-market transaction disclosed via SEC Form 4.

Expected impact

Likely limited/short-lived impact; any move would be sentiment-driven rather than thesis-changing.

Evidence & confidence

The filing is a single officer sale with no accompanying company-specific operational or financial update, and insider sales are often routine.

Market effects

Retail/discount apparel peers may see minor sentiment read-through, but no direct sector catalyst is provided.

None indicated; US-listed issuer-specific filing.

None indicated; transaction is company-internal insider activity.

Counterpoint

Without a 10b5-1 plan, the sale could reflect diversification/tax planning rather than bearish expectations.

Key entities

  • TJX COMPANIES INC /DE/

    Subject of the SEC Form 4 insider sale by an officer.

  • Canestrari Kenneth

    SEVP - Group President who sold 31,447 TJX shares at ~$157.50/share.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TJXHighAI 8/10

TJX Raises Fiscal 2027 Outlook as Q2 Results Show Broad-Based Growth

TJX raised its fiscal 2027 profit and earnings outlook after Q2 results exceeded expectations. Adjusted earnings rose 11% to $1.22 per share, and net sales increased 5% to $15.18 billion. Management also increased its long-term store target. Marmaxx, the largest division, showed the weakest growth at 1%, while other divisions performed better.

$TJXMedAI 8/10

Should Investors Buy TJX as Growth Improves but Valuation Stays Rich?

TJX reported strong Q2 results with rising sales and raised its fiscal 2027 earnings guidance to $5.15-$5.20 per share. The company plans to expand its store count to 7,500 and accelerate growth. However, its valuation remains high, with a forward P/S ratio of 2.06, above industry and historical averages. TJX's cash flow and shareholder returns are robust, but execution and cost pressures remain risks.

$TJXHighAI 8/10

TJX Falls 17.4% in the Past Month as Strong Results Meet Key Risks

TJX Companies Inc. (TJX) shares fell 17.4% in the past month despite beating Q2 earnings estimates and raising its full-year outlook. Q2 sales rose 5% to $15.18B, but Marmaxx's 1% comparable sales growth missed expectations. Management cited merchandise mix issues. TJX faces cost pressures from wages, fuel, and currency fluctuations, with Q3 gross margin expected to decline. The stock's valuation remains high, trading at a premium to its sub-industry and historical median.

$TJXMed

Tjx stock hits 52-week low at 125.5 USD

TJX Companies' stock hit a 52-week low of $125.49, down 26% from its high. Despite a 1-year decline of 9.66% and YTD losses of 17%, InvestingPro suggests it may be undervalued. Q2 fiscal 2027 results beat estimates, with $15.2B revenue and $1.22 EPS. Analysts have mixed views, with Jefferies downgrading to Hold, Bernstein maintaining Outperform, and UBS raising its target to $198.